Arbutus Biopharma Corp. (ABUS)
4.20
-0.01
(-0.24%)
USD |
NASDAQ |
Oct 23, 16:00
4.20
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Market Cap : 830.06M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 830.06M |
| October 22, 2026 | 832.04M |
| October 21, 2026 | 826.11M |
| October 20, 2026 | 855.76M |
| October 19, 2026 | 835.99M |
| October 16, 2026 | 834.02M |
| October 15, 2026 | 847.85M |
| October 14, 2026 | 828.09M |
| October 13, 2026 | 812.28M |
| October 12, 2026 | 820.18M |
| October 09, 2026 | 834.02M |
| October 08, 2026 | 826.11M |
| October 07, 2026 | 847.85M |
| October 06, 2026 | 885.40M |
| October 05, 2026 | 922.95M |
| October 02, 2026 | 879.47M |
| October 01, 2026 | 901.21M |
| September 30, 2026 | 944.69M |
| September 29, 2026 | 926.90M |
| September 28, 2026 | 960.50M |
| September 25, 2026 | 958.53M |
| September 24, 2026 | 964.45M |
| September 23, 2026 | 958.53M |
| September 22, 2026 | 990.15M |
| September 21, 2026 | 988.17M |
| Date | Value |
|---|---|
| September 18, 2026 | 990.15M |
| September 17, 2026 | 1.002B |
| September 16, 2026 | 998.05M |
| September 15, 2026 | 1.000B |
| September 14, 2026 | 1.014B |
| September 11, 2026 | 1.012B |
| September 10, 2026 | 1.012B |
| September 09, 2026 | 1.022B |
| September 08, 2026 | 1.024B |
| September 04, 2026 | 1.018B |
| September 03, 2026 | 1.012B |
| September 02, 2026 | 1.008B |
| September 01, 2026 | 1.006B |
| August 31, 2026 | 1.004B |
| August 28, 2026 | 1.002B |
| August 27, 2026 | 1.022B |
| August 26, 2026 | 1.026B |
| August 25, 2026 | 1.028B |
| August 24, 2026 | 1.028B |
| August 21, 2026 | 1.030B |
| August 20, 2026 | 942.71M |
| August 19, 2026 | 984.22M |
| August 18, 2026 | 956.55M |
| August 17, 2026 | 930.86M |
| August 14, 2026 | 922.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gossamer Bio, Inc. | 58.69M |
| Legend Biotech Corp. | 3.734B |
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
Market Cap Related Metrics
| PE Ratio | 5.361 |
| PS Ratio | 4.490 |
| Price to Book Value | 3.208 |
| Price | 4.20 |
| Earnings Yield | 18.65% |
| Operating PE Ratio | 5.534 |
| Normalized PE Ratio | 5.401 |